Please login to the form below

Not currently logged in
Email:
Password:

Envigo appoints Patricia Henahan as chief financial officer

She brings experience from AZ, Eli Lilly and Hospira

Envigo Patricia HenahanResearch company Envigo - formerly known as Huntindon Life Sciences - has appointed Patricia Henahan as its new chief financial officer.

Henahan brings 15 years of financial experience in the life science sector, including senior leadership roles at AstraZeneca, Eli Lilly and MedImmune.

Most recently, she served as vice president of finance for Hospira's US commercial operations.

Brian Cass, chief executive officer at Envigo, said: “I am delighted that Pat has decided to join the team at Envigo.

“Her background in pharmaceuticals and experience across the research and development process will bring valuable insight to our strategic planning as we continue to position Envigo as a leading provider of contract services and research models globally.”

21st June 2016

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics